Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Laurent Vernillet, PharmD, PhD, FCCP
Executive Director, Clinical Pharmacology
BioCryst Pharmaceuticals Inc
Poster(s):
152: Inhibition of the Complement Alternative Pathway in Healthy Subjects by an Oral Factor D Inhibitor
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT
165: No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction between Berotralstat & the Progestin Oral Contraceptive Desogestrel
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT
